Creative Planning
MRKR icon

Creative Planning’s Marker Therapeutics MRKR Stock Holding History

Creative Planning’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.5K Hold
17,312
– – ﹤0.01% 4044
2025
Q4 		$25.8K Hold
17,312
– – ﹤0.01% 3837
2025
Q3 		$15.5K Hold
17,312
– – ﹤0.01% 3826
2025
Q2 		$26.5K Hold
17,312
– – ﹤0.01% 3577
2025
Q1 		$21.3K Hold
17,312
– – ﹤0.01% 3400
2024
Q4 		$53.8K Hold
17,312
– – ﹤0.01% 3239
2024
Q3 		$48.8K Hold
17,312
– – ﹤0.01% 3100
2024
Q2 		$94K Hold
17,312
– – ﹤0.01% 2847
2024
Q1 		$74.4K Hold
17,312
– – ﹤0.01% 2749
2023
Q4 		$95.2K Hold
17,312
– – ﹤0.01% 2576
2023
Q3 		$78.6K Hold
17,312
– – ﹤0.01% 2422
2023
Q2 		$53.7K Sell
17,312
-250
-1% -$435 ﹤0.01% 2433
2023
Q1 		$12.5K Sell
17,562
-602
-3% -$1.43K ﹤0.01% 2452
2022
Q4 		$48.3K Hold
18,164
– – ﹤0.01% 2235
2022
Q3 		$67K Hold
18,164
– – ﹤0.01% 2088
2022
Q2 		$60K Buy
18,164
+660
+4% +$2.19K ﹤0.01% 2032
2022
Q1 		$77K Hold
17,504
– – ﹤0.01% 2017
2021
Q4 		$166K Buy
17,504
+2,968
+20% +$39.4K ﹤0.01% 1902
2021
Q3 		$246K Sell
14,536
-500
-3% -$10.2K ﹤0.01% 1719
2021
Q2 		$420K Sell
15,036
-1,100
-7% -$29K ﹤0.01% 1376
2021
Q1 		$361K Buy
+16,136
New +$369K ﹤0.01% 1669
2020
Q2 		– Sell
-2,450
Closed -$47K – 2086
2020
Q1 		$47K Buy
+2,450
New +$62.4K ﹤0.01% 1639

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Creative Planning's MRKR Position: Q1 2026 in Review

Creative Planning held its Marker Therapeutics (MRKR) position steady in Q1 2026 at 17,312 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.

Creative Planning first reported a position in MRKR in Q1 2020 and has held it in 22 quarters since. The position peaked at $420K in Q2 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Creative Planning held 17,312 shares of Marker Therapeutics worth $22.5K as of Q1 2026.
  • Creative Planning left its Marker Therapeutics share count unchanged in Q1 2026.
  • Marker Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4044 holding.
  • Creative Planning first reported a position in Marker Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • Creative Planning's Marker Therapeutics position peaked at $420K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.